| April, 10th, PLoS Genetics publication
Reutlingen and Berlin, Germany, April 10, 2019 – A study on tumor heterogeneity and its impact on patients’ response to cancer chemotherapeutics has been published in the peer-reviewed journal PLoS Genetics by academic partners and collaborators from the industry, including CPO cellular phenomics & oncology, the NMI Natural and Medical Sciences Institute at the University of Tübingen, and NMI TT Pharmaservices.
The full text of this publication is accessible online: https://doi.org/10.1371/journal.pgen.1008076